Table of Contents Author Guidelines Submit a Manuscript
Critical Care Research and Practice
Volume 2013, Article ID 782573, 9 pages
http://dx.doi.org/10.1155/2013/782573
Research Article

Outcomes of Severe Sepsis and Septic Shock Patients on Chronic Antiplatelet Treatment: A Historical Cohort Study

1Multidisciplinary Epidemiology and Translational Research in Intensive Care (METRIC), Mayo Clinic, Rochester, MN 55905, USA
2Department of Anesthesiology, Mayo Clinic, Rochester, MN 55905, USA
3Division of Pulmonary and Critical Care Medicine, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA

Received 29 November 2012; Accepted 18 January 2013

Academic Editor: Edward A. Abraham

Copyright © 2013 Juan C. Valerio-Rojas et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. S. Martin, D. M. Mannino, S. Eaton, and M. Moss, “The epidemiology of sepsis in the United States from 1979 through 2000,” The New England Journal of Medicine, vol. 348, no. 16, pp. 1546–1554, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. S. M. Lobo, E. Rezende, M. F. Knibel et al., “Early determinants of death due to multiple organ failure after noncardiac surgery in high-risk patients,” Anesthesia and Analgesia, vol. 112, no. 4, pp. 877–883, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. T. van der Poll, M. Levi, C. E. Hack et al., “Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees,” Journal of Experimental Medicine, vol. 179, no. 4, pp. 1253–1259, 1994. View at Google Scholar · View at Scopus
  4. M. A. Boermeester, P. A. M. van Leeuwen, S. M. Coyle, G. J. Wolbink, C. E. Hack, and S. F. Lowry, “Interleukin-1 blockade attenuates mediator release and dysregulation of the hemostatic mechanism during human sepsis,” Archives of Surgery, vol. 130, no. 7, pp. 739–748, 1995. View at Google Scholar · View at Scopus
  5. S. J. H. van Deventer, H. R. Buller, J. W. ten Cate, L. A. Aarden, C. E. Hack, and A. Sturk, “Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways,” Blood, vol. 76, no. 12, pp. 2520–2526, 1990. View at Google Scholar · View at Scopus
  6. M. Levi and T. van der Poll, “Inflammation and coagulation,” Critical Care Medicine, vol. 38, no. 2, supplement, pp. S26–S34, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. J. W. Semple and J. Freedman, “Platelets and innate immunity,” Cellular and Molecular Life Sciences, vol. 67, no. 4, pp. 499–511, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Levi, “The coagulant response in sepsis and inflammation,” Hamostaseologie, vol. 30, no. 1, pp. 10–16, 2010. View at Google Scholar · View at Scopus
  9. M. Gawaz, T. Dickfeld, C. Bogner, S. Fateh-Moghadam, and F. J. Neumann, “Platelet function in septic multiple organ dysfunction syndrome,” Intensive Care Medicine, vol. 23, no. 4, pp. 379–385, 1997. View at Publisher · View at Google Scholar · View at Scopus
  10. Q. Pu, E. Wiel, D. Corseaux et al., “Beneficial effect of glycoprotein IIb/IIIa inhibitor (AZ-1) on endothelium in Escherichia coli endotoxin-induced shock,” Critical Care Medicine, vol. 29, no. 6, pp. 1181–1188, 2001. View at Google Scholar · View at Scopus
  11. R. A. Chaer, J. A. Graham, and L. Mureebe, “Platelet function and pharmacologic inhibition,” Vascular and Endovascular Surgery, vol. 40, no. 4, pp. 261–267, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Lipcsey, A. Larsson, M. Olovsson, J. Sjölin, and M. B. Eriksson, “Early endotoxin-mediated haemostatic and inflammatory responses in the clopidogrel-treated pig,” Platelets, vol. 16, no. 7, pp. 408–414, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. H. R. O'Neal Jr., T. Koyama, E. A. S. Koehler et al., “Prehospital statin and aspirin use and the prevalence of severe sepsis and acute lung injury/acute respiratory distress syndrome,” Critical Care Medicine, vol. 39, no. 6, pp. 1343–1350, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Winning, J. Neumann, M. Kohl et al., “Antiplatelet drugs and outcome in mixed admissions to an intensive care unit,” Critical Care Medicine, vol. 38, no. 1, pp. 32–37, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. D. P. Eisen, D. Reid, and E. S. McBryde, “Acetyl salicylic acid usage and mortality in critically ill patients with the systemic inflammatory response syndrome and sepsis,” Critical Care Medicine, vol. 40, no. 6, pp. 1761–1767, 2012. View at Publisher · View at Google Scholar
  16. G. P. Otto, M. Sossdorf, J. Boettel et al., “Effects of low-dose acetylsalicylic acid and atherosclerotic vascular diseases on the outcome in patients with severe sepsis or septic shock,” Platelets. In press.
  17. D. J. Kor, J. Erlich, M. N. Gong et al., “Association of prehospitalization aspirin therapy and acute lung injury: results of a multicenter international observational study of at-risk patients,” Critical Care Medicine, vol. 39, no. 11, pp. 2393–2400, 2011. View at Publisher · View at Google Scholar
  18. J. M. Erlich, D. S. Talmor, R. Cartin-Ceba, O. Gajic, and D. J. Kor, “Prehospitalization antiplatelet therapy is associated with a reduced incidence of acute lung injury: a population-based cohort study,” Chest, vol. 139, no. 2, pp. 289–295, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. V. Herasevich, B. W. Pickering, Y. Dong, S. G. Peters, and O. Gajic, “Informatics infrastructure for syndrome surveillance, decision support, reporting, and modeling of critical illness,” Mayo Clinic Proceedings, vol. 85, no. 3, pp. 247–254, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. W. A. Knaus, D. P. Wagner, E. A. Draper et al., “The APACHE III prognostic system: risk prediction of hospital mortality for critically III hospitalized adults,” Chest, vol. 100, no. 6, pp. 1619–1636, 1991. View at Google Scholar · View at Scopus
  21. F. Baratto, F. Michielan, M. Meroni, A. Dal Palù, A. Boscolo, and C. Ori, “Protein C concentrate to restore physiological values in adult septic patients,” Intensive Care Medicine, vol. 34, no. 9, pp. 1707–1712, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. R. P. Dellinger, J. M. Carlet, H. Masur et al., “Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock,” Critical Care Medicine, vol. 32, no. 3, pp. 858–873, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. R. C. Bone, W. J. Sibbald, and C. L. Sprung, “The ACCP-SCCM consensus conference on sepsis and organ failure,” Chest, vol. 101, no. 6, pp. 1481–1483, 1992. View at Google Scholar · View at Scopus
  24. R. P. Dellinger, M. M. Levy, J. M. Carlet et al., “Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008,” Critical Care Medicine, vol. 36, no. 1, pp. 296–327, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. G. R. Bernard, A. Artigas, K. L. Brigham et al., “The American-European Consensus Conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination,” American Journal of Respiratory and Critical Care Medicine, vol. 149, no. 3, part 1, pp. 818–824, 1994. View at Google Scholar · View at Scopus
  26. R. L. Mehta, J. A. Kellum, S. V. Shah et al., “Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury,” Critical Care, vol. 11, no. 2, article R31, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Závada, E. Hoste, R. Cartin-Ceba et al., “A comparison of three methods to estimate baseline creatinine for RIFLE classification,” Nephrology Dialysis Transplantation, vol. 25, no. 12, pp. 3911–3918, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. R. P. McEver, “Selectins: lectins that initiate cell adhesion under flow,” Current Opinion in Cell Biology, vol. 14, no. 5, pp. 581–586, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Gando, “Microvascular thrombosis and multiple organ dysfunction syndrome,” Critical Care Medicine, vol. 38, no. 2, supplement, pp. S35–S42, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. N. Semeraro, C. T. Ammollo, F. Semeraro, and M. Colucci, “Sepsis, thrombosis and organ dysfunction,” Thrombosis Research, vol. 129, no. 3, pp. 290–295, 2012. View at Publisher · View at Google Scholar
  31. A. R. L. Gear and D. Camerini, “Platelet chemokines and chemokine receptors: linking hemostasis, inflammation, and host defense,” Microcirculation, vol. 10, no. 3-4, pp. 335–350, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. A. S. Weyrich and G. A. Zimmerman, “Platelets: signaling cells in the immune continuum,” Trends in Immunology, vol. 25, no. 9, pp. 489–495, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. V. Evangelista, S. Manarini, G. Dell'Elba et al., “Clopidogrel inhibits platelet-leukocyte adhesion and platelet-dependent leukocyte activation,” Thrombosis and Haemostasis, vol. 94, no. 3, pp. 568–577, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. C. C. Garcia, R. Guabiraba, F. M. Soriani, and M. M. Teixeira, “The development of anti-inflammatory drugs for infectious diseases,” Discovery Medicine, vol. 10, no. 55, pp. 479–488, 2010. View at Google Scholar · View at Scopus
  35. M. J. Paul-Clark, T. van Cao, N. Moradi-Bidhendi, D. Cooper, and D. W. Gilroy, “15-epi-lipoxin A4-mediated induction of nitric oxide explains how aspirin inhibits acute inflammation,” Journal of Experimental Medicine, vol. 200, no. 1, pp. 69–78, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. T. Morris, M. Stables, A. Hobbs et al., “Effects of low-dose aspirin on acute inflammatory responses in humans,” Journal of Immunology, vol. 183, no. 3, pp. 2089–2096, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. M. J. Yin, Y. Yamamoto, and R. B. Gaynor, “The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β,” Nature, vol. 396, no. 6706, pp. 77–80, 1998. View at Publisher · View at Google Scholar · View at Scopus
  38. E. Abraham, “Nuclear factor-κB and its role in sepsis-associated organ failure,” Journal of Infectious Diseases, vol. 187, supplement 2, pp. S364–S369, 2003. View at Publisher · View at Google Scholar · View at Scopus
  39. C. C. Sheu, M. N. Gong, R. Zhai et al., “Clinical characteristics and outcomes of sepsis-related vs non-sepsis-related ARDS,” Chest, vol. 138, no. 3, pp. 559–567, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. C. D. Goff, R. S. Corbin, S. D. Theiss et al., “Postinjury thromboxane receptor blockade ameliorates acute lung injury,” Annals of Thoracic Surgery, vol. 64, no. 3, pp. 826–829, 1997. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Zarbock, K. Singbartl, and K. Ley, “Complete reversal of acid-induced acute lung injury by blocking of platelet-neutrophil aggregation,” Journal of Clinical Investigation, vol. 116, no. 12, pp. 3211–3219, 2006. View at Publisher · View at Google Scholar · View at Scopus
  42. S. M. Bagshaw, S. Uchino, R. Bellomo et al., “Septic acute kidney injury in critically ill patients: clinical characteristics and outcomes,” Clinical Journal of the American Society of Nephrology, vol. 2, no. 3, pp. 431–439, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Yokota, J. I. Kambayashi, M. Sakon et al., “The possible involvement of platelet activation in endotoxin-induced renal insufficiency in a rabbit model,” Japanese Journal of Surgery, vol. 21, no. 5, pp. 542–546, 1991. View at Google Scholar · View at Scopus
  44. M. Levi, E. Eerenberg, and P. W. Kamphuisen, “Bleeding risk and reversal strategies for old and new anticoagulants and antiplatelet agents,” Journal of Thrombosis and Haemostasis, vol. 9, no. 9, pp. 1705–1712, 2011. View at Publisher · View at Google Scholar
  45. J. Valerio-Rojas, J. Cabello-Garza, D. Kelm, O. Gajic, and R. Cartin-Ceba, “Antiplatelet therapy and disseminated intravascular coagulation in septic shock patients: propensity score analysis,” American Journal of Respiratory and Critical Care Medicine, vol. 183, article A4698, 2011. View at Google Scholar